Drug Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
LDOS | B | Leidos Holdings, Inc. | 0.53 | |
ATHA | C | Athira Pharma, Inc. | 1.98 | |
BLTE | C | Belite Bio, Inc. | 0.55 | |
ITCI | C | Intra-Cellular Therapies Inc. | 0.77 | |
CSBR | C | Champions Oncology, Inc. | -0.21 | |
NMRA | D | Neumora Therapeutics, Inc. | -0.41 | |
AZTA | D | Azenta, Inc. | 0.82 | |
ALMS | D | Alumis Inc. | -2.43 | |
CDXS | D | Codexis, Inc. | -0.35 | |
MNMD | D | Mind Medicine (MindMed) Inc. | 2.59 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Semiconductor Equipment & Materials
Related Stock Lists:
Biopharmaceutical
Biotechnology
Pharmaceutical
Health Sciences
Neuroscience
Pharmacology
Artificial Intelligence
Biology
Disease
Life Sciences
Medication
Pharmaceutical Products
Pharmaceutical Sciences
Pharmacy
Active Pharmaceutical Ingredients
Advanced Solid Tumors
Alzheimer's Disease
Amyloidosis
Antibodies
Autism Spectrum Disorder
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
XPH | D | SPDR S&P Pharmaceuticals ETF | 6.11 | |
ROYA | D | Tema Global Royalties ETF | 4.88 | |
IHE | B | iShares U.S. Pharmaceutical ETF | 4.85 | |
PILL | F | Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF | 4.71 | |
PJP | C | PowerShares Dynamic Pharmaceuticals | 3.42 |
Compare ETFs
Related Industries:
Biotechnology
Diagnostics & Research
Drug Manufacturers - Specialty & Generic
Information Technology Services
Semiconductor Equipment & Materials
Related Stock Lists:
Biopharmaceutical
Biotechnology
Pharmaceutical
Health Sciences
Neuroscience
Pharmacology
Artificial Intelligence
Biology
Disease
Life Sciences
Medication
Pharmaceutical Products
Pharmaceutical Sciences
Pharmacy
Active Pharmaceutical Ingredients
Advanced Solid Tumors
Alzheimer's Disease
Amyloidosis
Antibodies
Autism Spectrum Disorder
- Drug Development
Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes pre-clinical research on microorganisms and animals, filing for regulatory status, such as via the United States Food and Drug Administration for an investigational new drug to initiate clinical trials on humans, and may include the step of obtaining regulatory approval with a new drug application to market the drug.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles